KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Amortization of Deferred Charges: 2009-2021

Historic Amortization of Deferred Charges for Dynavax Technologies (DVAX) over the last 7 years, with Dec 2021 value amounting to $2.7 million.

  • Dynavax Technologies' Amortization of Deferred Charges rose 7.01% to $702,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $2.7 million, marking a year-over-year increase of 5.97%. This contributed to the annual value of $2.7 million for FY2021, which is 5.97% up from last year.
  • As of FY2021, Dynavax Technologies' Amortization of Deferred Charges stood at $2.7 million, which was up 5.97% from $2.6 million recorded in FY2020.
  • Dynavax Technologies' Amortization of Deferred Charges' 5-year high stood at $3.4 million during FY2019, with a 5-year trough of $2.6 million in FY2020.
  • For the 3-year period, Dynavax Technologies' Amortization of Deferred Charges averaged around $2.9 million, with its median value being $2.7 million (2021).
  • As far as peak fluctuations go, Dynavax Technologies' Amortization of Deferred Charges fell by 24.09% in 2020, and later climbed by 5.97% in 2021.
  • Yearly analysis of 3 years shows Dynavax Technologies' Amortization of Deferred Charges stood at $3.4 million in 2019, then decreased by 24.09% to $2.6 million in 2020, then climbed by 5.97% to $2.7 million in 2021.